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ABSTRACT
Background: Little research has been conducted to describe the relationship between kidney
stones and risk of cardiovascular disease and stroke in individuals of different race ethnicities.
Purpose: The purpose of this study was to compare the prevalence of co-morbidities and to
investigate whether there was a statistically significant association between kidney stone formers
and increased odds of cardiovascular disease and stroke in race-ethnicity groups.
Methods: Data from the 2007-2012 cycles of the National Health and Nutrition Examination
Survey (NHANES) were used. Survey and biological data used included kidney stone cases,
hypertension, obesity, diabetes, chronic kidney disease, cardiovascular disease and stroke.
Covariates in the analytic models included ratio of family income to poverty, age, gender,
education, diet, smoking and tobacco use, poverty level, physical activity, and alcohol use.
Results: After adjusting for confounders, kidney stone participants had increased odds of
obesity, hypertension, diabetes, cardiovascular disease, and stroke. Non-Hispanic black kidney
stone formers, compared to other ethnic groups, had the highest prevalence of obesity (65.6%),
hypertension (67.6%), diabetes (37.8%), and stroke (6.1%). However, Mexican American kidney
stone formers had the highest prevalence of elevated cholesterol (38.2%), with non-Hispanic
white kidney stone formers having the highest prevalence of cardiovascular disease (7.1%).
Conclusion: We observed a relatively strong association between kidney stones and various
morbidities, with these observations not appearing to be moderated by race-ethnicity. However,
when utilizing the Pooled Cohort Equations to predict 10-yr risk of a future ASCVD event,
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kidney stones was only associated with future risk among non-Hispanic Black kidney stone
formers
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CHAPTER I

INTRODUCTION

Nephrolithiasis, or kidney stone events, affect approximately 10% of the U.S. population
(The National Institute of Diabetes and Digestive and Kidney Diseases (NDDK, 2013). The
number of Americans suffering from kidney stones between 2007 and 2010 nearly doubled from
1990s (Ferraro et al., 2013). Kidney stones are crystals formed in the kidney that become trapped
in the urinary tract. The kidneys naturally produce crystal-promoting and inhibiting substances,
which are carried in urine. Crystal inhibitors include: urine volume, citrate, magnesium, phylate,
and pyrophosphate. Crystal promoters include: calcium, sodium, phosphorous, struvite, uric acid,
and the amino acid cysteine. Kidney stones develop when an imbalance of crystal promoters and
inhibitors exist due to lifestyle factors, genetics, or other conditions (University of WisconsinMadison, 2010).
Kidney stones can arise in a variety of areas including the renal tubules, ureters, or
bladder. Stones can be asymptomatic or large enough, as in case of staghorn calculi, to cause
urinary obstruction and serious kidney damage. The obstruction caused by kidney stones could
lead to chronic kidney disease (CKD) that may progress to end-stage renal failure (ESRF) and
replacement of the natural kidney function by dialysis or renal transplantation (Ahmed, Ahmed,
& Khalil, 2012). Similarly, kidney stones could predispose individuals to urinary tract infections,
1

cystitis, or pyonephrosis. However, the latest findings have found associations with increased
incidence of progressive CKD and ESRF (Hootan, 2003). Kidney stones cause a significant
amount of pain and 50% of diagnosed patients experience high rates of reoccurrence (Lotan et
al., 2012). Symptoms of kidney stones include: pain while urinating, blood in urine, sharp pain in
the back, nausea, and vomiting (NDDK, 2013). The economic burden of kidney stones has
increased since 2000, with reported medical costs of $5.3 billion in 2010 (Saucier et al., 2010).
Risk factors for kidney stones, cardiovascular disease and stroke overlap and are
interrelated. Kidney stone events are more prevalent amongst people with hypercholestermia,
hypertension, obesity, and diabetes (Daudon, Traxer, Conort, Lacour & Jungers, 2006; Hamano
et al., 2005; Ramey, Franke, & Shelley, 2004; Saucier et al., 2010; Taylor et al., 2005). NonHispanic white men have been identified as having the highest risk for development of kidney
stones and associated medical conditions, such as gout, diabetes, and gallstone disease (Akoudad
et al., 2010). Although these findings are well established, little research has been conducted to
describe the relationship between kidney stones and risk of cardiovascular disease (CVD) and
stroke across race-ethnicities, even though minority populations have significant health
disparities in relation to hypertension, obesity, type-2 diabetes, high cholesterol, cardiovascular
disease, and stroke (Centers for Disease Control and Prevention, 2014a).
The non-Hispanic black population is thought to have a low prevalence of kidney stones
when compared to the non-Hispanic white population (Akoudad et al., 2010; Ferraro et al., 2013)
while not much is known about prevalence and incidence of kidney stones in the non-Hispanic
black population and its association with other diseases. Significant health disparities are seen
among other ethnic groups as well. In 2011, the age-adjusted percentage for diabetes in Mexican
Americans was 10%, while non-Hispanic whites were at 5.9% (CDC, 2014b) and little is known
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about the prevalence of kidney stones within these populations. The purpose of this study is to
compare the prevalence of co-morbidities (obesity, hypertension, diabetes, cholesterol,
cardiovascular disease, and stroke) within race-ethnicity groups, and to investigate whether there
is a statistically significant association between kidney stone formers and increased odds of
cardiovascular disease and stroke between race-ethnicity groups. A non-stone forming
population for each ethnic group will be used for comparison purposes. The investigation of
potential risk factors will include measures of obesity, diabetes, hypertension, total cholesterol,
cardiovascular disease and stroke.
Significance of the Study
This study will the question of whether non-Hispanic black persons who form kidney
stones (and other ethnic group kidney stone formers) have increased odds of experiencing
cardiovascular disease or stroke event. This study also will provide insight of whether the
relationship between kidney stones and an increased risk of cardiovascular disease found in other
research studies is consistent across race-ethnicity groups. The findings could contribute to
cardiovascular and public health research in the non-Hispanic black population, as they are
known as having the highest risk of death from end-stage renal failure and cardiovascular
disease. In addition, the findings could determine whether clinical protocol in urology and
nephrology should be altered (e.g. increase health education for kidney stone formers) in order to
prevent heart disease. There could be a need for heart disease prevention discussions for patients
with kidney stones and biological factors should be considered (such as calcium deposition,
biomarker screening, and management of morbidities such as, obesity, hypertension, and
diabetes). Non-Hispanic black and other subpopulations with risk factors for kidney stones will
benefit from this study, as these factors are related to cardiovascular disease.
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Research Hypotheses
Hypothesis 1: I hypothesized kidney stone formers would have greater prevalence and greater
odds of co-morbidities, and that non-Hispanic black kidney stone formers would have the
greatest prevalence and greatest odds of co-morbidities when compared to other race-ethnicity
groups. The non-stone forming population would have a lower prevalence of co-morbidities.
Hypothesis 2: Based on previous literature (Hamano et al., 2005; Torricelli et al., 2014), I
hypothesized that total cholesterol would mediate the relationship between kidney stone presence
and cardiovascular disease/stroke. Further, I hypothesized that hypertension and obesity will
mediate the relationship between kidney stone presence, cardiovascular disease and stroke.
Hypothesis 3: I hypothesized that individuals with kidney stones and obesity, and those with
kidney stones and hypertension would have a greater odds of having cardiovascular disease and
stroke than those with just kidney stones, just obesity, and just hypertension.
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CHAPTER II

REVIEW OF LITERATURE

Nephrolithiasis affects the middle aged adult population, more significantly adults 40
years or older (Mayo Clinic, 2014). It also significantly affects the non-Hispanic white
population more than other racial-ethnic groups. Additional risk factors for nephrolithiasis
include dehydration, family history of kidney stones, digestive surgeries, and diets high in
protein, sugar, and sodium. The rate of kidney stones has increased significantly over the past
two decades, and it is believed to be due to the increases in rates of diabetes and obesity (Ferraro
et al., 2013). The causes of kidney stone events are multifactorial, but relationships have been
found between type 2-diabetes (Daudon, Traxer, Conort, Lacour, & Jungers, 2006; West et al.,
2008), obesity (Taylor et al., 2005; West et al., 2008), hypertension, (Cappuccio, Strazzullo, &
Mancini, 1990; Dai, Zhao, Liu, You, & Wang, 2013; Ramey, S., Franke, W., & Shelley, M.,
2004; West et al., 2008), high cholesterol levels (Hamano et al., 2005; Torricelli et al., 2014),
and kidney stones. Previous research has also shown baseline kidney stone formers to have an
increased risk of cardiac events such as myocardial infarction, fatal coronary heart disease, and
coronary artery bypass surgery (Ferraro et al., 2013; Rule et al., 2010).

5

Obesity
Obesity is defined as a body mass index (BMI) greater than or equal to 30. Obesity
affects approximately 34.9% of the U.S. adult population (CDC, 2014d). Approximately 37.9%
of non-Hispanic black men and 57.6% of non-Hispanic black women are obese (CDC, 2015). In
2010, the adult obese population in the United States was approximately 72.5 million.
Approximately 41% of obese adults had incomes at or above 350% of the poverty level, 39%
had incomes between 130% and 350% of poverty level and 20% had incomes below 130% of the
poverty level. Non-Hispanic black men and women with incomes between 130% and 350% of
the poverty level had higher rates of obesity than non-Hispanic black men and women above the
350% mark or below the 130% mark. Additionally, Mexican American men with income at or
above 130% suffer from greater rates of obesity than Mexican American men and women below
130% of poverty line. According to the NCHS Data Brief, there were no significant differences
in the prevalence of obesity by poverty level in the non-Hispanic white men, but there were
significant differences in non-Hispanic white women (Ogden, Lamb, Carroll, & Flegal, 2010).
Obese individuals are at an increased risk for many adverse conditions, such as
hypertension, diabetes mellitus, cardiovascular disease, and even some cancers (Ogden et al.,
2010). Larger body size and weight gain also increases the risk of kidney stone formation.
Excessive nutritional intake increases the presence of lithogenic substances in the body, such as
calcium, oxalate, and uric acid, which contribute to calcium, oxalate, and uric acid stones
(Asplin, 2009). Obesity also causes irregular kidney function by raising blood pressure with
increased renal tubular absorption (Hall et al., 2014) and causing kidney weight gain (Ahmed et
al., 2012).
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Research suggests that incidence of kidney stone disease is directly associated with
weight and BMI. Curan, Willett, Rimm, Speizer, and Stampfer (1998) found the magnitude of
the association between kidney stones and weight varies by gender. Assessing two large cohorts:
The Nurses’ Health Study (n = 89376 women) and the Health Professionals Follow-up Study (n
= 51529 men), they found the incidence of kidney stones to be greater amongst women
participants (n = 1078) when compared to men (n = 953), and found women to have higher
BMIs. The relative risk of developing a kidney stone was 1.89 (1.51 to 2.36) in women and 1.19
(0.83 to 1.70) in men.
Siener, Glatz, Nicolay, and Hesse (2004) evaluated the prevalence of obese and
overweight participants to determine the influence of weight on the risk of calcium oxalate stone
disease. Their findings contradicted those of Curan et al. (1998); stone disease was more
common in overweight and obese men (n = 363) than in overweight and obese women (n = 164).
Stone events were also highest amongst overweight and obese men when compared to normal
weight men (p = .028). This study found that increasing BMI was associated with a higher risk of
calcium oxalate stone formation in both genders (p = .015) but the highest risk was for men with
higher BMI (p = .047). In addition to high risk of stone formation, 49% of overweight men had
one or more of the following: hypertension, cardiovascular disease, diabetes, gout, gallstone
disease, and hyperuricemia. Seventy-four percent of the obese men had at least one of the comorbidities. Forty-four percent of overweight women had at least one of the co-morbidities,
while 59% of obese women had at least two of the co-morbidities. This study concluded that
weight influenced calcium oxalate stone formation significantly because higher weight causes an
increase of urinary crystal promoters and does not increase the urinary crystal inhibitors.
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Therefore more opportunities for calcium oxalate crystal stone formation occur in those who are
obese.
Urinary pH, especially a persistently low pH (< 5.5) has been shown to greatly contribute
to the development of uric acid nephrolithiasis (Pak, Sakhaee, & Peterson, 2001). Maalouf et al.
(2004) found an inverse association between urinary pH and elevated bodyweight after analyzing
medical data derived from University of Texas Southern Medical Center (Texas group; n = 1130
men and 585 women) and The University of Chicago (Chicago group; n = 2121 men and 1047
women). The mean age for the Texas group was 43 years and the mean weight was 79kg
(approximately 174.17 pounds). The mean age for the Chicago group was 44 years and the mean
weight was 80kg (approximately 176.37 pounds). Urinary pH was lowest (< 5.84) for individuals
that weighed more than 95kg (Dallas group; n = 285, Chicago group; n = 546). This study
suggested that low urinary pH was associated with the effects of obesity, which may sometimes
cause uric acid nephrolithiasis by producing excessive acids in urine caused by insulin resistance.
Zhou, Watts, Agalliu, DiVito and Hoenig (2013) conducted a study examining the
medical records of 269 patients with urinary stones and found visceral fat area (a marker of
visceral obesity) was significantly higher in uric acid stone formers when compared to non-uric
acid stone formers (209.3 vs. 161.9 cm2, p = 0.001). A high level of visceral fat was also reported
as an independent risk factor for uric acid nephrolithiasis (OR 3.64, 95% CI 1.22-10.85, p =
0.02) when compared to the low level of visceral fat area. This study concluded that in addition
to routine treatments for stones, other efforts should include lifestyle modifications to enhance
weight loss in order to effectively treat obese kidney stone formers.
Semins et al. (2010) analyzed the Blue Cross Blue Shield database to assess the affects
of BMI on the risk for kidney stone disease. They included more categories of obesity (BMI
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greater than 40 kg/m2) in addition to the lower categories of BMI. The 95,598 stone cases that
were identified consisted of 54,572 women and 41,025 men. The likelihood of the development
of a kidney stone was two times greater in men than in women and the likelihood also increased
with age (OR 1.44 for participants age 35-44 to OR 2.44 for participants age 55-64). Obese
participants (except for men with a BMI higher than 50 kg/m2) were significantly more likely to
develop a kidney stone than people with a BMI less than 30 kg/m2. Overall, this study
recognized that having a BMI that is considered “obese” increased the risk of kidney stone
disease, but once the body mass index is greater than 30 kg/m2 the level of risk stabilized. The
authors suggest that this stabilization may be due to an increase in urinary excretion of elements
that promote stone formation.

Hypertension
Hypertension or high blood pressure is defined as a systolic reading of 140mm Hg or
higher and a diastolic reading of 90mm Hg or higher. The systolic reading measures the pressure
in the arteries when the heart contracts and the diastolic reading measures the pressure in the
arteries between contractions (American Heart Association, 2015). Hypertension is a common
condition that causes damage to blood vessels and organs over time due to elevated pressure on
arteries and vessels. Approximately 78 million U.S. adults have been diagnosed with
hypertension and the number is expected to increase (American Heart Association, 2014a).
Symptoms of hypertension could be asymptomatic; many adults do not know they have the
disease until they visit a doctor or check their blood pressure.
Hypertension is considered to be a major risk factor for heart disease and kidney stones.
High blood pressure causes significant damage to the kidneys due to the damaging of blood
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vessels throughout the body, which makes it harder for the kidneys to remove waste and function
properly (Medical College of Wisconsin, 2014). African Americans, or non-Hispanic blacks, are
considered to have the highest risk for hypertension when compared to other ethnic groups
(American Heart Association, 2014). Approximately 43% of African American men and 45.7%
of African American women have high blood pressure. Mexican Americans are reported to have
27.8% of men and 28.9% of women with high blood pressure while Caucasians have 33.9% of
men and 31.3% of women with high blood pressure (CDC, 2014b). African Americans also
develop hypertension at an earlier age more often than other ethnic groups. African Americans
are at least six times more likely to develop kidney complications due to hypertension than their
Caucasian counterparts (CDC, 2014b).
Previous studies have found that a bidirectional relationship exists between hypertension
and kidney stones. Kidney stone formers have an increased risk of hypertension and hypertensive
individuals are at an increased risk for developing a kidney stone (Madore, Stampfer, Rimm,
Curhan, 1998). Renal damage from kidney stones may contribute to hypertension, and
hypertensive individuals may have higher concentrations of urinary calcium, which would cause
calcium stone formation (Cappuccio, Strazzullo, & Mancini, 1990). Studies have also revealed
significant gender differences in hypertensive kidney stone formers. Dai, Zhou, Liu, You, &
Wang (2013) and Akoudad et al. (2010) found that men with a history of hypertension were
more susceptible to developing kidney stones than women.
Cappuccio et al. (1990) examined 688 male hypertensive and normotensive individuals to
test whether kidney stone disease was more prevalent in people that were hypertensive. Sixtyone participants were previously diagnosed with hypertension and were receiving treatment. In
total, 118 participants were hypertensive and the untreated hypertensive participants were
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recognized as hypertensive at the time of screening. The prevalence of a history of stone disease
was 13.4% in the normotensive group, 20.3% in the untreated hypertension group, and 32.8% in
the diagnosed hypertension group. Treated hypertensive participants were heavier and older than
the other groups. After adjustments for age and BMI, the prevalence of kidney stones remained
higher in the treated and diagnosed hypertensive participants (age, F = 4.54; p =.011, BMI, F =
4.58; p = 0.011). Overall, their results concluded that hypertensive participants had twice the risk
of developing a kidney stone than normotensive participants (OR 2.63; 95% CI, 1.75 to 5.71).
Hall et al. (2001) assessed the risk factors of kidney stones in southern postmenopausal
women using the Women’s Health Initiative. Postmenopausal women from nine southern
Women’s Health Initiative Centers were enrolled for the study (n = 27,410). Of these women,
1,170 kidney stone formers were identified. When assessing the hypertensive women enrolled (n
= 887), 485 women had both hypertension and kidney stones (41.5%), which was greater than
the number of hypertensive women without a kidney stone (n = 402, 34.4%, p = 0.001).
Therefore, this study identified hypertension to be a risk factor for kidney stones in
postmenopausal women.
Madore, Stampfer, Rimm, & Curhan, (1998) conducted a similar study to determine
whether normotensive women participants with a history of kidney stones were more likely to
develop hypertension in the future compared to women participants with no history of kidney
stones. The Health Professionals Follow-up study was used to assess 51,529 men that were 40 to
75 years old. A total of 4,111 participants reported a history of kidney stones and 11,623
participants reported being diagnosed with hypertension. Statistical analysis revealed an
association between kidney stones and hypertension (age adjusted odds ratio, OR 1.31 95%
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confidence interval, CI 1.30 to 1.32). Overall, their study concluded that having a kidney stone
increases the risk of subsequent hypertension.

Diabetes
Diabetes is a condition caused by having high concentrations of glucose in the
bloodstream due to the absence of insulin or insufficient use of insulin. Beta cells store and
release insulin, which regulates glucose concentrations in the blood. The absence of beta cells
and inadequate production of insulin from beta cells cause diabetes. Diabetes is diagnosed using
hemoglobin A1C (“A” stands for adult type) blood test, which measures the average glucose in
the blood up to 3 months. Individuals with A1Cs greater than or equal to 6.5% are considered
diabetic. Plasma glucose levels greater than or equal to 200 mg/dL is also used to diagnose
diabetes. Risk factors for diabetes include: physical inactivity, family history of diabetes, low
HDL cholesterol, hypertension and obesity. In 2012, approximately 29.1 million people in the
United States (9.3% of population) identified as having diabetes (American Diabetes Association
(ADA), 2015). Non-Hispanic blacks are 1.7 times more likely to develop type 2 diabetes as
compared to non-Hispanic whites. According to the ADA, approximately 7.6% of non-Hispanic
whites are diabetic, 13.2% of non-Hispanic blacks are diabetic, and 13.9% of Mexican
Americans are diabetic. Diabetes dramatically increases the risk for complications and diseases
such as cardiovascular disease and kidney damage. High levels of glucose in blood vessels
damage the filtering function of the kidneys and can lead to chronic kidney disease and end-stage
renal failure (Mayo Clinic, 2014).
Research has shown type 2 diabetes to increase the risk of kidney stone formation due to
associated damage to kidney function (Cameron, Maalouf, Adams-Huet, Moe & Sakhaee, 2006;
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Meydan, Barutca, Calizkan, & Camsari, 2003; Taylor et al., 2005). The effects of diabetes elicit
kidney stone formation by altering urine composition thus effecting ammonium production. It
also causes elevated levels of plasma free fatty acids, which enters the urinary tract and interferes
with glutamine utilization during the process of ammonium production (Taylor et. al, 2005).
Insulin resistance contributes to the accumulation of acids such as ammonia, and significantly
lowers pH, which favors uric acid stone formation (Daudon, Traxer, Conort, Lacour, & Jungers,
2006). Low urine pH itself has an impact on the urinary tract’s ability to excrete acid, such as
citrate, which increases the risk for calcium-containing kidney stones (Taylor et al., 2005).
Taylor et al. (2005) conducted a study to evaluate the relationship between a history of
reported diabetes mellitus and the prevalence of kidney stones in men and women using the
Nurses’ Health Study (n = 121,700 older women, aged 30 – 55 years), the Nurse’s Health Study
II (n = 116,671 younger women, aged 25 – 42 years), and the Health Professionals Follow-up
Study (51,529 men, aged 40-75 years). Of these participants, 1,473 older women, 949 younger
women, and 1,568 men had a history of diabetes. After analysis, all three cohorts demonstrated a
relationship between kidney stones and a history of diabetes mellitus. The relative risk of a
kidney stone for individuals with diabetes compared to those without was 1.38 (95% CI 1.06 1.79) in older women, 1.67 (95% CI 1.28 - 2.20) in younger women, and 1.31 (95% CI 1.11 1.54) in men. The relative risk of kidney stones for individuals with diabetes compared to those
without was 1.29 (95% CI 1.05-1.58) in older women, 1.60 (95% CI 1.16-2.21) in younger
women, and 0.81 (95% CI 0.59-1.09) in men. The relative risk for incidence of diabetes in
subjects with kidney stones compared to those without was 1.33 (95% CI 1.18-1.50) in older
women, 1.48 (95% CI 1.14-1.91) in younger women, and 1.49 (95% CI 1.29-1.72) in men.
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Therefore, this study concluded that diabetes mellitus was associated with an increased odds for
the development of kidney stones.
Daudon et al. (2006) evaluated kidney stone types in people with and without type 2
diabetes, specifically comparing calcium and uric acid stones. A total of 40,718 stones were
analyzed from the Laboratoire Crystal. Two thousand four hundred and sixty four of these were
from 272 patients with type 2 diabetes. There were also 2192 stones that were analyzed from
patients without diabetes. The proportion of uric acid nephrolithiasis was significantly higher (3
times higher) in stone formers with type 2 diabetes than in patients without diabetes (p <
0.0001). Also, the proportion of stone cases from patients with type 2 diabetes was higher
amongst uric acid stone formers than calcium stone formers (27.8 versus 6.9%; p < 0.0001).
Type 2 diabetes was recognized as a major factor independently associated with risk of uric acid
stone formation (OR 6.9, 95% CI; 5.5 to 8.8). Researchers also noticed that the prevalence of
uric acid stones rose with age and BMI.
Cameron et al. (2006) also performed an analysis of patients with type 2 diabetes to
determine metabolic differences between stone formers and non-stone formers. Participants were
from the University of Texas Southern Medical Center in Dallas Texas. The stone formers (n =
8), non -stone formers (n = 24), and normal volunteers (n = 59) had significant differences in pH
levels. Urine pH was significantly lower in the stone forming population when compared to the
non-stone forming patients (p < 0.01). Also, the stone forming population had a higher
prevalence of obesity and hyperinsulinemia when compared to normal volunteers. Low urine pH
was concluded to be the main risk factor for the development of kidney stones in people with
type 2 diabetes.
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Total Cholesterol and Combined morbidities (Metabolic syndrome)
In addition to research on hypertension, obesity, and diabetes, studies have found
relationships between kidney stones and high cholesterol. High cholesterol levels occur when
there are fatty deposits in blood vessels, which increase the risk of a heart attack or stroke. High
cholesterol is defined as 240 mg/dL or greater (Mayo Clinic, 2015). Approximately 71 million
American adults have high low-density lipoprotein (LDL) cholesterol, and only 1 out of every 3
adults have controlled cholesterol levels (CDC, 2015). Research has linked high levels of
cholesterol with higher rates of kidney stones (Torricelli et al, 2014). In addition, Hamano et al.
(2005) identified hypercholesterolemia as one of several coronary heart disease risk factors for
calcium oxalate kidney stone formers. They conducted a case control study to examine 181
calcium oxalate stone formers and compared them to 187 control participants. The variables
examined included body mass index (BMI), current alcohol use, smoking, hypertension,
hypercholesterolemia, diabetes, and hyperuricemia. Multivariate logistic regression revealed
statistical significance for smoking (OR 4.29, 95% CI; 2.68-6.86, p < 0.0001), hypertension (OR
3.57, 95% CI 2.11-6.07, p < 0.0001), and hypercholesterolemia (OR 2.74, 95% CI; 1.51-5.00, p
< 0.0001). Those with kidney stones had 2.74 increased odds of having high cholesterol.
Metabolic syndrome (MS) is defined as the grouping of factors that increase the risk for
heart disease (obesity, hypertension, increased serum triglyceride level, decreased serum highdensity lipoprotein cholesterol level, and diabetes mellitus), and affects approximately 30% of
the U.S. population (AHA, 2014b). Kohjimoto et al. (2013) examined whether the clustering of
metabolic syndrome traits increased the severity of kidney stone disease in 11,555 patients.
Overall, 61.7% had at least one trait, 65.2% had at least 2 traits, 69.3% had at least 3 traits, and
73.3% had at least 4 traits (p < 0.001). Their results showed that clustering of metabolic
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syndrome traits (obesity, diabetes, hypertension, and dyslipidemia) is associated with increased
risk of kidney stone formation. Participants of this study with four traits had a 1.8-fold greater
odds of multiple and/or recurrent stones compared with patients with zero traits (OR 1.78; 95%
CI, 1.22 - 2.66).
Sakhaee et al. (2012) measured whether calcium nephrolithiasis increased the risk of
metabolic syndrome in 128 recurrent calcium stone formers from Dallas, Texas and 140
recurrent calcium stone formers from Bern, Switzerland (both were compared to 109 non-stone
formers from Dallas Texas). They concluded that in non-stone formers, the risk of calcium
nephrolithiasis increased with the number of features of MS. They also found that stone formers
have a higher propensity for calcium oxalate nephrolithiasis, but the risk was not independently
associated with increasing features of MS. West et al. (2008) reported history of kidney stones
using The National Health and Nutrition Examination Survey III. Their results found that the
prevalence of kidney stones was associated with metabolic syndrome and the number of
metabolic syndrome traits increased the risk 7.5% if 3 traits were present and to 9.8% if 5 traits
were present. Participants with four or more traits had a 2-fold increase in odds of reported
kidney stones.

Cardiovascular disease and Stroke
Cardiovascular disease refers to a variety of conditions that contribute to the narrowing of
blood vessels, which hinder blood flow to and from the heart. Conditions of cardiovascular
disease include: coronary artery disease, atherosclerosis, heart arrhythmia, and congenital heart
defects (Mayo Clinic, 2013). The symptomology of cardiovascular disease varies from chest pain
discomfort or pain, shortness of breath, nausea or cold sweats. Having cardiovascular disease can
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also result in heart attacks or sudden death. Cardiovascular disease is the leading cause of death
for both men and women in the United States (CDC, 2013; Lee & Wildeman, 2013). In 2008, the
percentage of deaths caused by heart disease for non-Hispanic whites was 25.1%; for nonHispanic blacks, 24.5% of deaths, and for Hispanics, 20.8% of deaths. There is a greater
prevalence of cardiovascular disease, stroke, myocardial infarction, and atherosclerosis in the
non-Hispanic black community (Hollier, 2013). In 2013, non-Hispanic blacks 20 years or older
had cardiovascular disease rates of 44.4% in men and 48.9% in women. Percentages for nonHispanic blacks with coronary heart disease were 6.8% for men and 7.1% for women (AHA,
2013). In 2013, Mexican American adults age 20 years and older had cardiovascular disease
rates of 33.4% for men and 30.7% for women. Percentages for Mexican Americans with
coronary heart disease were 6.7% for men and 5.3% for women. Due to the higher prevalence of
the disease and its risk factors, cardiovascular disease is considered a major health disparity for
African Americans (Jackson Heart Study, 2013).
Similar to cardiovascular disease, strokes occur when there is an interruption of blood
supply and narrowing blood vessels leading to the brain, leading to brain cell damage. Strokes
can cause a variety of symptoms such as difficulty with speech, paralysis, blurred vision,
headaches, and loss of coordination. Approximately 85% of strokes are ischemic strokes, which
are caused by the narrowing of arteries that lead to the brain. Ischemic strokes are caused by
blood clots; these blood clots consist of fatty deposits and lipid radicals. Risk factors that
increase the risk of stroke include: obesity, high cholesterol, diabetes, physical inactivity,
excessive alcohol use, or heart disease (Mayo Clinic, 2015).
According to the CDC, stroke is the fifth leading cause of death in the United States. The
risk of stroke is twice as high for non-Hispanic blacks when compared to non-Hispanic whites.
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Additionally, non-Hispanic blacks are more likely to die after stroke events than non-Hispanic
whites. Following non-Hispanic blacks, Hispanics are also more likely to suffer from a stroke
when compared to non-Hispanic whites (CDC, 2015a).
Previous studies have found significant associations between kidney stones and increased
risk of cardiovascular disease and stroke. Rule et al. (2010) examined 4564 incident stone
formers from Olmsted County, MN. They found kidney stone formers to have a 38% higher risk
for myocardial infarction (HR 1.38; 95% CI 1.07-1.77). After adjustments for kidney disease,
hypertension, diabetes, obesity, dyslipidemia, gout, alcohol dependence, and tobacco use, the
increased risk remained (HR 1.31; 95% CI 1.02 to 1.69). A prospective study conducted by
Ferraro et al. (2013) determined there was a higher risk of developing coronary heart disease in
participants with a history of kidney stones after adjusting for high blood pressure, diabetes,
elevated cholesterol, and BMI (Hazard Ratio (HR) for Nurses’ Health Study I, 1.18 (95% CI
1.08 - 1.28); HR for Nurses’ Health Study II, 1.42 (95% CI 1.07 - 1.90). Domingos and Serra
(2011) examined the Portuguese National Health Survey and the prevalence of cardiovascular
disease, hypertension, diabetes, obesity, and stroke in kidney stone formers. When compared to
non-stone formers, there was a higher odds ratio of myocardial infarction (OR 1.338; 95% CI
1.003-1.786) and stroke (OR 1.330; 95% CI 1.015-1.743).
More recent studies, specifically meta-analyses and systematic reviews have also found
significant associations between a history of kidney stones and coronary heart disease.
Cheungpasitporn et al. (2014) examined four cohort studies and one cross-sectional study, which
included 52, 791 kidney stone patients. Calculated pooled risk ratios demonstrated significant
association between kidney stones and coronary heart disease (RR 1.24; 95% CI 1.10-1.40). The
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results remained significant for females (RR 1.34; 95% CI 1.12-1.82) but not for males (RR
1.14; 95% CI 0.94-1.38).
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CHAPTER III

METHODOLOGY

The primary objective for this study was to determine, among those with a reported
history of kidney stones, which race-ethnicity group(s) had an increased odds of cardiovascular
disease and stroke. Secondary objectives of this study was to 1) compare the prevalence of select
co-morbidities (i.e., obesity, hypertension, diabetes, and chronic kidney disease) in kidney stone
formers within race-ethnicity groups, while also comparing these co-morbidities in non-kidney
stone formers, 2) explore biological mechanisms to explain the possible relationship between
kidney stone presence and cardiovascular disease/stroke and 3) examine the potential combined
effects of kidney stone presence, obesity and hypertension on the odds of having cardiovascular
disease and stroke.

Participants
The sample used for this study included 20 – 79 year old men and women who
participated in the 2007-2012 cycles of the National Health and Nutrition Examination Survey
(NHANES). Race/ethnicities included: Mexican American, other Hispanic, non-Hispanic White,
non-Hispanic Black, and other race- including multi-racial persons. Notably, the ages 20-79
years were selected because only NHANES participants 20 and older were eligible for the

20

medical questionnaire used to assess the morbidities described herein, and participants 80 years
and older were top-coded as “80” in the NHANES dataset; inclusion of those with a coded value
of “80” years may induce biases related to residual confounding.
The University of Mississippi Institutional Review Board (IRB) requires review of
research involving human participants. Although this research involved data collected from
human participants, the IRB recognizes de-identified data that is publically available, such as
data from NHANES, exempt from IRB review. The exemption would have been denied if this
project merged multiple data sets that would enable the identification of human participants to be
known, which was not the case (U.S. Department of Health & Human Services, 2010). The
National Center for Health Statistics (NCHS) ethics review board protocol number for NHANES
cycles 2007-2010 is #2005-06 and the protocol number for cycles in 2011-2012 is #2011-17
(CDC, 2012).
The continuous NHANES survey represents the total civilian, non-institutionalized
population 2 months of age or older in the United States after 1999. The data collected in this
survey includes questionnaires administered at home and from physical examinations in mobile
examination centers (MECs). A complex, multistage, clustered probability sampling design was
used to select a representative sample of the U.S. civilian population. Four-stages are employed
in this design, including, 1) selection of the primary sampling units (PSUs), which consist of
counties, 2) selection of segments, which consist of cities embedded within the county 3) random
selection of households, and 4) random selection of individuals within households (average of
1.6 person per household). Beginning in 1999, the sample size collected each year was
approximately 5,000 and they were from at least 15 geographic regions across the United States.
Since then, the data has been released in 2 year intervals (e.g., 1999 - 2000, 2001 - 2002, etc.)
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(CDC, 2014c). For the purposes of this study, data gathered from years 2007 - 2012 will be used,
as these are the only NHANES cycles that collected kidney stone-related information.

Data Extraction
For this study, the primary outcomes of interest included kidney stone cases,
hypertension, diabetes, cardiovascular disease, stroke, and measured obesity (BMI ≥ 30kg/m2).
In order to control for parameters that would influence kidney stone presence and the other
evaluated morbidities, the following covariates were included in the analytic models: ratio of
family income to poverty, age, education level, smoking status, alcohol use, kidney disease, and
physical activity. The extraction and data verification process utilized to prepare for analyses
consisted of a series of 11 steps.
1) Go to the Center for Disease Control Prevention website and the continuous NHANES
homepage (http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm).
2) Locate variables relevant to hypotheses and analyses.
3) Download data files in a TEMP folder (because data is in SAS format).
4) Use Stata to open data files within the TEMP folder and save the data files in a
“DATA” folder. This is the method used to transfer data from SAS format to a Stata
format.
5) Examine data files and the associated codebooks to observe any changes or differences in
the data that occurred from each year.
6) Sort data by SEQN (variable ID) and merge the data to the master data file and append the
data across the cycles.
7) Identify missing data and recode values accordingly.
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8) Define the variables descriptively by labeling them. For example, define race with
numbers and description: 1=Mexican American 2= other Hispanic, etc.
9) Construct the 6-year sample weights
(http://www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/Weighting/Task2.htm)
10) Perform various data treatment procedures, including the reconstruction of variables to
create appropriate categories (e.g., use the two smoking questions to create four smoking
groups: smokes every day, some days, former smoker, and never smoker).
11) Compute the statistical analyses using survey-specific commands.

Study Variables
As displayed in Table 1, study variables included various chronic diseases, behavioral,
and demographic parameters. The chronic diseases, which were assessed from survey and
biological data (see Table 1), included kidney stone cases, hypertension, obesity, diabetes,
chronic kidney disease, cardiovascular disease and stroke. The behavioral and demographic
variables (assessed via survey), which were used for descriptive purposes as well as covariates in
the analytic models, included ratio of family income to poverty, age, gender, education, smoking
and tobacco use, poverty level, physical activity, and alcohol use.

Sample Size Determination
In the 2007-2012 NHANES cycles, 16,486 participants were 20-79 years of age. Among
these 16,486 participants, 15,716 provided data on the primary study variables (i.e., kidney stone
obesity, hypertension, etc.). Among these 15,716 participants, 13,006 provided data on the

23

covariates (i.e., ratio of family income to poverty, age, gender, education, smoking status,
alcohol, and physical activity). These 13006 participants constituted the analytic sample.

Analysis
All statistical analyses were computed in Stata Version 13 (StataCorp, College Station,
TX). Statistical significance was set at p < 0.05 for all analyses. Post-hoc achieved power
analysis was computed to examine the achieved statistical power for the analytical tests. Various
regression-related calibration and diagnostic tests were be employed. For example, studentized
residuals (a type of standardized residual) were examined to check for outliers; normality of
residuals was assessed using Lawrence C. Hamilton’s interquartile range procedure (e.g., nonnormality of residuals being those points that are either 3 inter-quartile ranges below the first
quartile or 3 inter-quartile ranges above the third quartile); heteroskedasticity was assessed using
the Breusch-Pagan/Cook-Weisberg test; multicollinearity was assessed via variance inflation
factors; model specification was assessed using the Stata linktest; and cell size was checked for
each variable to prevent numerical problems.

Aim 1 was to compare the prevalence of co-morbidities (obesity, hypertension, diabetes,
cardiovascular disease and stroke) in non-Hispanic Black kidney stone formers and kidney stone
formers within other race-ethnicity groups, while also comparing non-kidney stone formers.
Hypothesis 1: I hypothesized that kidney stone formers would have a greater prevalence
and greater odds of co-morbidities, and that non-Hispanic Black kidney stone formers
would have the greatest prevalence of co-morbidities when compared to other race-
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ethnicity groups. The non-stone forming population would have the lowest prevalence of
co-morbidities.
Analysis 1: Univariate analyses were used to report proportions of the evaluated
co-morbidities across the racial ethnicity groups. A chi-square test was used to
determine if there were proportional differences between the co-morbidities and
the race-ethnicity groups. Separate analyses were performed for each medical
condition (e.g. race-ethnicity groups and obesity, racial –ethnicity groups and
hypertension, etc.).
A multivariable logistic regression was used to examine the association between
kidney stone presence (independent variable) and each comorbidity (dependent
variable). A separate multivariable logistic regression model was used for each
comorbidity. A multivariable logistic regression model was used to examine the
association between kidney stone presence and multimorbidity (i.e., having at
least 2 of the evaluated diseases). In order to assess whether race-ethnicity
moderates the association between kidney stone presence and each comorbidity
(e.g., obesity), multiplicative statistical interaction was employed by creating a
cross-product term between the race-ethnicity and presence of kidney stone
variables along their main effects in a multivariable logistic regression model. If
the multiplicative statistical interaction variable was significant, effect
modification models were then employed separately for each race-ethnicity.
For the regression analyses, both unadjusted and adjusted results were presented.
Aim 2 was to examine biological mechanisms to explain the potential relationship between
kidney stone presence and cardiovascular disease and stroke.
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Hypothesis 2: Based on previous literature (Torricelli et.al, 2014), I hypothesized that
total cholesterol would mediate the relationship between kidney stone presence
cardiovascular disease/stroke. Further, I hypothesized that hypertension and obesity
would mediate the relationship between kidney stone presence, cardiovascular disease
and stroke.
Analysis 3: Baron and Kenny mediational analysis, using bootstrapped confidence
interval, was used to examine whether the above listed parameters mediated the
relationship between kidney stone presence and the identified morbidity. The
relative magnitude (effect size) of the indirect was be estimated by calculating the
mediation ratio (PM), which is the ratio of the indirect effect to the total effect:
PM=ab/(ab)+c, with ‘a’ being the slope linking kidney stone presence to the
mediator, ‘b’ is the conditional slope linking the mediator to the outcome, and ‘c’
is the conditional slope linking kidney stone presence to the outcome variable.
The ratio of indirect effect to the direct effect were calculated as: RM=ab/c.
Aim 4 was to examine whether there was an additive combined effect of kidney stone presence
and obesity, hypertension, diabetes and elevated cholesterol with cardiovascular and stroke.
Hypothesis 4: I hypothesized that individuals with kidney stones and obesity, and those
with kidney stones and hypertension would have a greater odds of having cardiovascular
disease and stroke than those with just kidney stones, just obesity, and just hypertension.
Analysis 4: To examine the potential combined effects of kidney stones and
obesity and kidney stones and hypertension, a morbidity index variable was
created by summing the number of morbidities they had (range 0-2). Two
multivariable logistic regression analyses were computed, one model
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included cardiovascular disease as the outcome variable and the other included
stroke as the outcome. For both models, the morbidity index
variable served as the independent variable with having 0 (vs. 1 and 2)
morbidities serving as the referent group for the morbidity index variable
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CHAPTER IV

RESULTS

Table 1 displays the characteristics of the study sample stratified by kidney stones status.
Those with kidney stones, compared to those without kidney stones, were more likely to be male
(56% vs. 48.6%), older (51.7 years vs. 45.2 years), and of non-Hispanic white origin (78.7% vs.
68.6%). Those with kidney stones when compared to those without kidney stones also had higher
BMI (30.3 kg/m2 vs 28.73 kg/m2), higher blood pressure (51.1% vs. 33.3), and had a higher
prevalence of diabetes (21.6% vs. 10.4%), high cholesterol (4.3% vs. 4.0%), kidney disease
(4.0% vs. 1.7), cardiovascular disease (6.4% vs. 2.3%), and stroke (4.5% vs. 2.0%).
Aim 1 was to compare the prevalence of co-morbidities (obesity, hypertension, diabetes,
cardiovascular disease and stroke) in non-Hispanic Black kidney stone formers and kidney stone
formers within other race-ethnicity groups, while also comparing non-kidney stone formers.
Table 2 displays the prevalence of comorbidities among race-ethnicity groups who have had a
kidney stone. Non-Hispanic black kidney stone formers, compared to Mexican Americans, other
Hispanic, and non-Hispanic white kidney stone formers, had the highest prevalence of obesity
(65.6%), hypertension (67.6%), diabetes (37.8%), and stroke (6.1%). However, Mexican
Americans had the highest prevalence of elevated cholesterol (38.2%), with non-Hispanic whites
having the highest prevalence of cardiovascular disease (7.1%).

28

Aim 2 was to determine whether there was a statistically significant association between
kidney stone formers and increased odds of the above-mentioned co-morbidities (obesity,
hypertension, diabetes, cardiovascular disease and stroke), and compare associations across
racial ethnicity groups. Table 3 displays the multivariable logistic regression results examining
the association between kidney stones and the previously-described morbidities; results are also
presented across race-ethnicity groups. Individuals with kidney stones (vs. no kidney stones) had
statistically significant increased odds of having each of the evaluated morbidities, with the
exception of elevated cholesterol. Specifically, kidney stone formers (vs. no kidney stones), had
a 49% increased odds of obesity, 63% increased odds of hypertension, 86% increased odds of
diabetes, 68% increased odds of cardiovascular disease, and 68% increased odds of stroke.
There was little evidence of effect modification by race-ethnicity regarding the kidney
stone-morbidity relationship; significant associations between kidney stones and morbidity status
was observed for each race-ethnicity group. With regard to non-Hispanic black kidney stone
formers, they had a 97% increased odds of obesity, 60% increased odds of hypertension, and an
82% increased odds of diabetes. All models were adjusted for age, gender, physical activity,
education, smoking, alcohol, total caloric intake, dietary protein intake, dietary calcium intake,
and dietary sodium intake.
Aim 3 was to examine biological mechanisms to explain the potential relationship
between kidney stone presence, cardiovascular disease, and stroke. The Barron and Kenny
mediational analyses were computed to examine whether select potential mediators (total
cholesterol and hypertension) mediated the relationship between kidney stones and
cardiovascular disease/stroke; all mediational analyses controlled for the covariates described in
the previous models. Mediation analyses indicated that the indirect effect of total cholesterol on
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the relationship between kidney stones and cardiovascular disease was significant (β = .006;
bootstrapped 95% CI: .01-.001; p <. 05), with a relatively small effect; the proportion of the
total effect mediated was 7%. Similarly, the indirect effect of total cholesterol on the relationship
between kidney stones and stroke was significant (β = .02; bootstrapped 95% CI: .001-.01; p <
.05), with a relatively small effect; the proportion of the total effect mediated was 3.9%.
The indirect effect of hypertension on the relationship between kidney stones and
cardiovascular disease was not significant (β = .01; bootstrapped 95% CI: -.0001-.001; p > .05),
with a relatively small effect; the proportion of the total effect mediated was 15.3%. However,
the indirect effect of hypertension on the relationship between kidney stones and stroke was
significant (β = .01; bootstrapped 95% CI: .007-.02; p < .05), with a relatively modest effect; the
proportion of the total effect mediated was 22.9%.
Aim 3 was to examine whether there was an additive combined effect of kidney stones
with each of the morbidities (kidney stones and obesity, kidney stones and hypertension, kidney
stones and diabetes and kidney stones and elevated cholesterol). We examined the impact of the
combined effect on risk of cardiovascular disease and stroke. There was consistent evidence of a
combined effect of kidney stones and the evaluated morbidities on cardiovascular disease (Table
4). Those with kidney stones and obesity (vs. not) had a 2.36 fold increased odds of having
cardiovascular disease; and those with kidney stones and hypertension (vs. not) had an 85%
increased odds of cardiovascular disease. In addition, those with kidney stones and obesity (vs.
not) had a 57% increased odds of stroke; those with kidney stones and hypertension (vs. not) had
a 2.08 fold increased odds of having stroke.
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Pooled Cohort Equations
The main limitation of the previous analyses was the cross-sectional design, which
precludes an inability to ascertain temporal sequence. For example, it is plausible to suggest that
kidney stones may influence cardiovascular disease risk, but it is equally plausible to suggest that
cardiovascular disease, or morbidities associated with cardiovascular disease (e.g., hypertension),
may precipitate the development of kidney stones. In an effort to address this directionality issue,
additional analyses were computed that examined the association of kidney stones on the
predicted risk of cardiovascular disease within the next 10 years.
Predicted 10-yr risk for a first atherosclerotic cardiovascular disease (ASCVD) event for
adults 40-79 years (age range equations derived from) was calculated using the Pooled Cohort
Equations, developed by the American College of Cardiology/American Heart Association
(ACC/AHA) Task Force on Practice Guidelines (Golf et al., 2013). These equations have
demonstrated evidence of validity (Mutner et al., 2014; Park et al., 2014)
Pregnant women or participants on cholesterol medication or who had been told by a
doctor or other health professional that they had congestive heart failure, coronary heart disease,
angina, heart attack, or stroke were excluded from these ASCVD analyses, which resulted in a
sample of 5,571 adults 40-79 years of age, free of cardiovascular disease. Separate equations
were developed for black and white/other men and women, which included the following
variables in the equations: age (yrs), concentration of total cholesterol (mg/dL) and HDLcholesterol (mg/dL), treated or untreated systolic blood pressure (mmHg), diabetes status
(defined here as physician diagnosis or A1C ≥ 6.5%), and self-reported smoking status (yes/no).
Participants with an ASCVD score of ≥ 7.5% were considered to be at an elevated risk for
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future cardiovascular events while participants with an ASCVD score of ≥20% were considered
to be at high risk for future cardiovascular events.
After adjustments (same covariates as in previous models), having kidney stones was not
associated with an increase odds of having an ASCVD event within the next 10-years (OR =
1.03; 95% CI: 0.58-1.82, p = 0.91). When stratified by race-ethnicity, results were also nonsignificant for Mexican Americans (OR = 1.35; 95% CI: 0.42-4.29), other Hispanic (OR 1.02;
95% CI: 0.21-4.85), and non-Hispanic whites (OR 0.81, 95% CI: 0.40-1.61). However, among
non-Hispanic blacks, those with kidney stones had a 2.24 increased odds (OR 2.24; 95% CI:
1.08-4.66; p = 0.03) of having an ASCVD event within the next 10-years when compared to nonHispanic blacks with no history of a kidney stone.

32

Table 1: Characteristics of the analyzed participants in the 2007-2012 National Health and
Nutrition Examination Survey (N=13006)
Variables
Gender (%)
Male
Female
Age (Years)
Race-ethnicity (%)
Mexican American
Other Hispanic
Non-Hispanic White
Non-Hispanic Black
Other Race
Average # of times passed a stone
BMI (kg/m2) ≥ 30
Hypertension (%)
Diabetes (%)
Total to HDL cholesterol Ratioa
Kidney Disease (%)
Cardiovascular Disease (%)
Stroke (%)
Education (%)
High School or less
Some college or more
Alcohol use (%)b
Non-drinker
Light to moderate drinker
Heavy Drinker
Smoking
Smokes everyday
Smokes some days
Former Smoker
Never smoked
Physical Activity in past 30 days
(Y/N)
Moderate to vigorous
work/recreational physical activity
(YES)
Energy (kcal)
Calcium (mg)
Sodium (mg)
Protein (g)

Kidney stones (n=1,140)

No kidney stones
(n=11,866)

p*
Value

56 (51.7-60.2)
44 (39.8-48.3)
51.7 (50.8-52.6)

48.6 (47.6-49.7)
51.3 (50.3-52.4)
45.2 (44.4-45.9)

.0023

5.9 (3.6-8.2)
5.1 (2.9-7.3)
78.7 (73.8-83.6)
5.6 (3.7-7.5)
4.6 (2.6-6.6)
2.25
30.3 (29.9-30.7)

8.5 (6.3-10.6)
5.3 (3.9-6.7)
68.6 (64.5-72.7)
11.2 (9.1-13.3)
6.3 (5.3-7.4)
0
28.7 (28.5-28.9)

<.001

51.1 (47.3-54.8)
21.6 (18.3- 24.9)
4.3 (4.2-4.4)
4.0 (2.7-5.4)

33.3 (31.7-34.8)
10.4 (9.7-11.4)
4.0 (3.9-4.1)
1.7 (1.3-2.1)

<.001
<.001
<.001
.001

6.4 (4.8-8.1)
4.5 (3.2-5.7)

2.3 (1.9-2.8)
2.0 (1.7-2.4)

<.001
<.001
.1006

42.3 (37.9-46.8)
57.7 (53.2-62.1)

39.2 (36.5-41.9)
60.8 (58.1-63.5)

30.5 (26.5-34.5)
38.9 (34.1-43.6)
30.6 (27.2-34.1)

24.5 (22.7-26.2)
35.3 (33.6-37.1)
40.2 (38.6-41.7)

19.2 (15.9-22.5)
2.3 (1.4-3.2)
27.7 (23.9-31.5)
50.8 (45.6-56.1)

17.8 (16.2-19.4)
3.5 (3.0-4.0)
24 (22.5-25.4)
54.7 (52.7-56.6)

69.2 (65.8-72.5)

74.1 (72.4-75.8)

.003

2166.6 (2087.7-2245.5)
944 (901.6-986.3)
3626.5 (3489.3-3763.8)
81.5 (78.4-84.6)

2216.48 (2188.9-2244.1)
1000.7 (981.6-1019.8)
3628.5 (3581.5-3675. 5)
84.5 (83.4-85.7)

.23
.01
.97
.0475

<.001
<.001

<.001

.04

*P-Value <.05. An adjusted Wald test was used for continuous variables and a design-based likelihood ratio test was used to
determine proportional differences for the categorical variables.
a Total cholesterol ratio was calculated by calculating the ratio of total to HDL cholesterol
b Light-to-moderate drinker defined as 1 alcoholic drink/day for women and 1-2 alcoholic drinks/day for men; heavy drinker
defined as 2 or more alcoholic drinks/day for women and 3 or more alcoholic drinks/day for men
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Table 2: Prevalence of morbidities in kidney stone formers stratified by race-ethnicity: 20072012 NHANES (N=1,164)
Race-ethnic
groups with
Kidney stones
Mexican
American
Other
Hispanic
Non-Hispanic
White
Non-Hispanic
Black

Obesity (%)

Hypertension
(%)

Diabetes
(%)

48
(39.3-56.6)
44.6
(339-55.2)
44.2
(39.4-49)
65.6
(58.9-72.3)

46.4
(38.4-54.5)
42.8
(32.3-53.3)
50.3
(45.7-55)
67.6
(59.7-75.6)

26.9
(19.5-34.3)
17.1
(11.3-23.0)
19.3
(15.9-22.6)
37.8
(11.4-44.2)

Total
Cholesterol
(%)
38.2
(28.5-47.8)
35.8
(27.0-44.5)
35.6
(30.7-40.5)
27.6
(17.7-37.6)

CVD (%)

Stroke (%)

3.6
(1.1-6.2)
4.8
(2.0-7.5)
7.1
(5.0-9.1)
1.5
(-.30-3.2)

5.2
(1.6-8.8)
2.8
(.52-5.1)
4.6
(3.1-6.1)
6.1
(2.8-9.4)

Table 3: Results of multivariate logistic regression examining the association between kidney
stones and morbidities: 2007-2012 NHANES (N=13,006).

OR (95%
CI) Obesity

OR (95% CI)
Hypertension

OR (95%
CI) Diabetes

Kidney stones vs.
non-kidney
stones – Entire
Sample
By RaceEthnicity

1.49
(1.28-1.75)

1.63
(1.35-1.96)

1.86
(1.5-2.31)

Mexican
American
Other
Hispanic
NH-White

1.15
(.82-1.62)
1.33
(.80-2.25)
1.42
(1.13-1.80)
1.97
(1.37-2.81)

1.89
(1.22-2.92)
1.68
(1.06-2.66)
1.56
(1.24-1.96)
1.60
(1.05-2.45)

1.71
(.96-3.03)
.98
(.53- 1.83)
1.78
(1.38-2.29)
1.82
(1.32-2.52)

NH-Black
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OR (95%
CI) High
Cholesterol

OR (95%
CI) CVD

OR (95%
CI) Stroke

1.12
(.95-1.32)

1.68
(1.16-2.45)

1.68
(1.15-2.45)

1.14
(.72-1.82)
.93
(.59-1.47)
1.06
(.86-1.30)
1.62
(.68-1.98)

1.95
(.77-4.91)
2.89
(1.26-6.63)
1.70
(1.12-2.58)
.56
(.144-2.16)

2.91
(1.19-7.12)
2.54
(.86-7.46)
1.79
(1.11-2.89)
1.03
(.5092.08)

Table 4: Association of kidney stones and presence of other morbidities on odds of having
cardiovascular and cerebrovascular disease.

Kidney Stones vs. No
Kidney Stone
Kidney Stones & Obesity
vs. Not
Kidney Stones &
Hypertension vs. Not
Kidney Stones & Diabetes
vs. Not

OR (95% CI) Cardiovascular
Disease
1.68 (1.16-2.45)

OR (95% CI) Stroke
1.68 (1.15-2.45)

2.36 (1.54-3.63)

1.57 (.94-2.61)

1.85 (1.11-3.08)

2.08 (1.32-3.29)

3.83 (2.36-6.23)

1.83 (1.04-3.2)
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CHAPTER V

DISCUSSION

The purposes of this study were to examine the interrelationships between kidney stones,
cardiovascular disease and stroke, as well as various morbidities, such as obesity, hypertension,
diabetes, and high cholesterol. Additionally, we were interested in examining potential
parameters that may mediate the relationship between kidney stones and cardiovascular disease
and stroke.
When comparing those who have had or have kidney stones to those without a history of
kidney stones, kidney stone formers had statistically significant increased odds of all of the
morbidities, with the exception of elevated cholesterol. Specifically, kidney stone formers had a
49% increased odds of obesity, 63% increased odds of hypertension, 86% increased odds of
diabetes, 68% increased odds of cardiovascular disease, and 68% increased odds of stroke. Our
cross-sectional analyses did not demonstrate non-Hispanic black kidney stone formers as having
an increased odds of all morbidities when compared to the other races, but did demonstrate nonHispanic Black kidney stone formers as having a 97% increased odds of obesity, 60% increased
odds of hypertension, and an 82% increased odds of diabetes. Although our analyses did not
demonstrate a strong moderation effect of race-ethnicity (i.e., other race-ethnicity groups were
also significant), analyses via Pooled Cohort Equations revealed that non-Hispanic blacks, and
no other ethnicity groups, had an increased risk of future cardiovascular disease. Specifically,
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non-Hispanic black kidney stone formers had a 2.24 increased odds of having an ASCVD event
within the next 10-years when compared to non-Hispanic blacks with no history of a kidney
stone.
To our knowledge, this is the first study to comprehensively examine the
interrelationships between kidney stones and various morbidities, while considering raceethnicity specific effects. To date, there have been two meta-analyses that have examined the
prospective relationship between kidney stones and cardiovascular disease. Liu et al. (2014)
examined six cohort studies and, as supported by each of these six studies, determined that
kidney stones conferred a higher risk for myocardial infarction and coronary revascularization.
Cheungasitporn et al. (2014) examined four cohort studies and one cross-sectional study
with these studies showing that a history of kidney stones was associated with increased risk of
coronary heart disease in females. Both meta-analyses included the prospective study conducted
by Ferraro et al. (2013); their results demonstrated a higher risk of developing coronary heart
disease in participants with a history of kidney stones after adjusting for high blood pressure,
diabetes, elevated cholesterol, and BMI, suggesting that, perhaps, other non-cardiometabolic
parameters may be mediating the relationship between kidney stones and future cardiovascular
disease. Notably, however, the study by Ferraro and colleagues also reported a higher prevalence
of obesity, hypertension, diabetes, and elevated cholesterol in those with kidney stones when
compared to those without. Approximately 95% of the population employed in their prospective
study identified as being “White”, while the remainder of the population identified as “NonWhite”. Our study found that non-Hispanic White kidney stone formers had higher odds of
morbidities, but the odds were not as high as other ethnicity groups, such as Mexican Americans
and non-Hispanic Blacks.
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When using the Framingham and Systematic Coronary Risk Evaluation equations,
Ferraro and colleagues also found a higher 10-year risk of cardiovascular disease for kidney
stone formers when compared to non-kidney stone formers. Our study assessed 10-year risk of
an ASCVD event using the Pooled Cohort Equations in all ethnicity groups within NHANES; we
found that only non-Hispanic black kidney stone formers had a higher ASCVD risk score when
compared to non-Hispanic black non kidney stone formers. Taken together, our findings are in
partial support of those by Ferraro et al. (2013) by demonstrating an association between kidney
stones and various morbidities; however, our findings extend those of Ferraro et al. and other
studies by showing that non-Hispanic blacks with kidney stones have an increased 10-year risk
of an ASCVD event, as determined using the Pooled Cohort Equations.
Individuals with a history of kidney stones have a 50% chance of developing stones again
(Lotan et al., 2012). Approximately 75% of reported kidney stones are composed of
calcium/calcium oxalate. Calcium kidney stones have shown to be similar to vascular calcium
plaque found in coronary vessels. The observed link that exists between kidney stones,
cardiovascular disease, and stroke may be attributed to shared pathophysiological mechanisms.
Vascular calcification (i.e. deposition of calcium into the blood vessel structures) occurs when
there are abnormally high concentrations of calcium and phosphate, due to insufficient or
defective calcification inhibitors (Lomashvili, Garg, Narisawa, Milan, & O’Niel, 2010).
Similarly, kidney stones develop when there is an imbalance of crystal promoters and inhibitors
(University of Wisconsin-Madison, 2010). Pyrophosphate, a phosphorous oxyanion, is an
inhibitor of calcification and crystallization, and is present in both the heart and kidney,
respectively. Insufficient or low concentrations of pyrophosphate cause arterial calcification and
kidney crystallization (Lomashvili et al., 2010). Therefore those with kidney stones could have a
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deficiency of inhibitors (crystal inhibitors include: urine volume, citrate, magnesium, phylate,
etc.) from continued development of kidney stones, which would lead to subsequent
cardiovascular disease and stroke.
Kidney stones, CVD, and stroke also share pathways such as vascular endothelial injury
and endothelial dysfunction (Reiner et al., 2011). Hyperuricemia, or high uric acid levels, have
been associated with both kidney stones and cardiovascular disease. Uric acid acts as a
proinflammatory agent, ultimately increasing levels of C-reactive protein (CRP). Raised CRP
levels are indicative of possible arterial damage and endothelial dysfunction, providing another
potential mechanism explaining the kidney stone-CVD relationship as endothelial dysfunction is
a major risk factor for CVD (Hadi, Carr, & Suwaidi, 2005). Uric acid also impairs renal nitric
oxide levels, which effectively reduces hypertension and renal injury (Zoccali, Maio, Mallamaci,
Sesti, & Perticone, 2006), both of which are also contributors to CVD (Weiner et al., 2004).
In addition to chronic kidney stone formation influencing CVD/stroke risk via
insufficient inhibitors and endothelial injury, another possible mechanism is shared risk factors
of kidney stone formers and those with cardiovascular disease and stroke. Lifestyle factors such
as dietary habits, physical activity, and water intake are shared factors that influence
development of morbidities, kidney stones, and cardiovascular disease/stroke (AHA, 2015).
Individuals with kidney stones tend to have unhealthy profiles, including higher rates of obesity
(Siener et al., 2004), higher rates of hypertension (Madore, Stampfer, Rimm, & Curhan, 1998),
and diabetes (Taylor et al., 2005). Hypertension is recognized as the single most contributive
factor of development of stroke and cardiovascular disease (World Heart Federation, 2015). It is
possible that having a kidney stone increases risk of the development of hypertension via
alterations in calcium metabolism.
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According to the CDC, non-Hispanic Blacks tend to have higher rates of
morbidities when compared to other race-ethnicities. A greater disparity is seen in the prevalence
of hypertension. Approximately 43% of African American men and 45.7% of African American
women have high blood pressure. Other ethnicities, such as Mexican Americans, have 27.8% of
men and 28.9% of women with high blood pressure; Caucasians have 33.9% of men and 31.3%
of women with high blood pressure (CDC, 2014b). Non-Hispanic blacks are also at least six
times more likely to develop kidney complications due to hypertension than their Caucasian
counterparts (CDC, 2014b). Currently, there is no definitive explanation of why non-Hispanic
blacks in the United States have a higher prevalence of hypertension. Researchers speculate a
combination of genetic factors, dietary factors, and environmental factors as possible
contributors. According to the “slavery hypertension hypothesis”, African Americans have a
genetic predisposition for hypertension caused by salt deficiency in African slaves, the distress
caused by the slave trade, and slavery conditions in the United States. Due to genetic
predisposition, African slaves had an enhanced ability to conserve salts, which provided
protection from salt-depletive diseases. Higher rates of hypertension are thus seen in African
descendants, who now consume much higher sodium in American foods (Fuchs, 2011). Many
find this hypothesis difficult to accept and difficult to refute because there have not been genetic
racial differences between U.S. born African descendants and native Africans, when the
hypothesis speculates a bottleneck occurred when slaves traveled via Middle Passage. Although
researchers argue about the genetic disposition component of the hypothesis, salt sensitivity
among African Americans are apparent; intakes of just half a teaspoon can cause a rise in blood
pressure as much as five points (Armelagos, 2005). In addition, the chronic stress component of
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the hypothesis is considered valid, as many researchers today identify chronic stress as a
determinant of health disparities.
Recently, environmental factors, such as the anticipation of racial discrimination or
harassment, have also been found to be associated with the hypertension prevalence seen in nonHispanic blacks in the United States. This hyper-reactivity to stress from vigilance can activate
the hypothalamic-pituitary response systems. Repeated activation over periods of time can cause
elevated levels of cortisol and adrenocorticotrophic hormone even when the stressor is no longer
present, which has been linked to hypertension. Stress also elicits endothelial dysfunction by
activation of the sympathetic nervous system (SNS). Repeated activation of the SNS causes
damage to tissues, which triggers hypertension (Hall et al., 2012). Hicken, Lee, Morenoff,
House, & Williams (2014) found racism related vigilance to be positively associated with
hypertension in non-Hispanic blacks, but not in non-Hispanic whites. For every reported increase
in vigilance, there was 4% greater odds of hypertension (OR= 1.04; 95% CI=1.00-1.09). A
significant association between hypertension and dimensions of discrimination (specifically,
lifetime discrimination and greater burden of discrimination) was also found in an all nonHispanic black prospective study (Sims et al, 2011). When comparing the highest to the lowest
level of discrimination, hypertension was 8% to 9% higher amongst non-Hispanic blacks after
adjusting for age, gender, and socioeconomic status (PR =1.08; 95% CI = 1.02- 1.15).
According to Hall et al. (2012), the role of renal excretion of water and electrolytes is a
major part of blood pressure regulation. The two hormones, renin and aldosterone, both regulate
mean arterial pressure by maintaining extracellular volume in the presence of salt. In this renalbody fluid feedback mechanism, renin activates a raise in blood pressure to restore pressure
regulation in the kidneys. In cases of increased sodium intake and raised aldosterone levels in
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proportion with renin levels, blood pressure becomes unregulated. The continued elevation of
aldosterone causes an imbalance of pressure natriuresis, which causes hypertension. Elevated
aldosterone levels also result in organ damage and changes in cardiac output. When considering
race ethnicity, this hormone abnormality (low renin hypertension) is more prevalent among nonHispanic blacks, thus possibly explaining differences in hormone regulation and how this
regulation impacts mean arterial pressure in non-Hispanic blacks (Rifkin et al., 2014). We found
non-Hispanic Black kidney stone formers to have a 60% increased odds of hypertension when
compared to non-Hispanic Whites. The relationship that exists between hypertension and kidney
stones could be the mechanism that explains why African American kidney stone formers had a
higher risk of cardiovascular disease 10 years later.
Another possible mechanism that could explain why a relationship was found between
kidney stones and higher risk of an ASCVD event in non-Hispanic blacks could be decreased
vitamin D levels seen in non-Hispanic blacks. Vitamin D is a fat soluble vitamin that acts as a
regulator of calcium and phosphorus; a risk factor for low vitamin D is darker skin pigmentation
(melanin in skin inhibits UV (ultraviolet) penetration; UV penetration (sunlight) activates
production of vitamin D). Non-Hispanic blacks are notorious for having vitamin D
concentrations below doctor recommendations (between 20-30 ng/ml) (Harris, 2006). Reduced
levels of vitamin D are contributive to both kidney stones and fatal cardiovascular consequences.
Specifically, low vitamin D elevates calcium levels, which results in both kidney stones and
endothelial dysfunction. Because calcium levels are unregulated, the concentration of calcium in
the urinary tract increases, which results in calcium stones. Deficient concentrations of vitamin D
also induce adhesion molecule expression and inference with endothelial-dependent contractions.
Vitamin D receptors, present in cardiac muscle cells, regulate calcium levels in the cell. In mice
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experiments, increased free calcium in cardiac muscle cells modified contractibility of the heart,
cellular hypertrophy, and heart rate ratio (Nemerovski et al, 2009). Also, vitamin D deficiency is
mediated by elevated plasma parathyroid hormone which directly targets endothelial cells
(Muscogiuri et. al, 2012). Secondary hyperparathyroidism develops in result of inadequate
levels of vitamin D, which directly impacts blood pressure and the contractibility of the heart.
Given our observed findings that those with kidney stones have increased odds of various
morbidities, it is important for clinicians to consider introduction of prevention techniques (such
as weight management and ways to prevent hypertension) for cardiovascular disease and stroke
as a part of their protocol for kidney stone formers in order to prevent future disease.
Additionally, biological factors, such as calcium deposition, biomarker screening, and
management of other morbidities should be introduced to kidney stone patients in order to
prevent chronic disease. Clinicians should also consider potential race-ethnicity effects among
their kidney stone patients, as, for example, non-Hispanic blacks with a history of kidney stones
had an increased predicted risk for a future ASCVD event.
Major strengths of this study include the utilization of a national sample and the
comprehensive assessment of the interrelationships between kidney stones, morbidity, and future
risk of an ASCVD event. However, despite these strengths, notable limitations included the
inability to determine the type of stone and how long participants’ had a history of kidney stones.
Further, another limitation was the cross-sectional design employed in NHANES, rendering
temporal sequence not possible. In an attempt to overcome this limitation, we utilized the Pooled
Cohort Equations to predict future risk of an ASCVD event, which were developed from
multiple prospective investigations (Goff et al., 2013; Kandula et al., 2014; Muntner et al., 2014;
Park et al., 2014).
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In conclusion, we observed a relatively strong association between kidney stones and
various morbidities, including hypertension and self-report history of cardiovascular disease and
stroke, with these observations not appearing to be moderated by race-ethnicity. However, when
utilizing the Pooled Cohort Equations that were derived from prospective investigations to
predict 10-yr risk of a future ASCVD event, kidney stones was only associated with future risk
among non-Hispanic black kidney stone formers. In order to confirm our findings, future
prospective studies examining the association of kidney stones with cardiovascular disease and
stroke with broader race-ethnicity categories and age ranges are warranted.
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